BehindLines

England: a sponge test for the oesophagus under review

· BehindLines newsroom

The British public body NICE, which issues guidance for the English health system, published draft recommendations for consultation on 16 November 2026. It proposes wider use of so-called "sponge" tests to look for abnormalities of the oesophagus, according to the BBC and to NICE's own statement.

A test carried out outside hospital

According to the BBC, the patient swallows a small capsule on a thread. It dissolves in the stomach and releases a tiny sponge, which the doctor then gently pulls back out; on the way it picks up cells from the oesophageal lining, which are then analysed. NICE says the tests need no sedation and can take place in primary care or in community diagnostic centres instead of at the hospital. The BBC describes them as less invasive than an endoscopy, which uses a small camera, and as possible in a few minutes.

The two devices and the people concerned

NICE's independent committee selected two devices, Cytosponge and EndoSign, for people with persistent gastro-oesophageal reflux. They are used to detect Barrett's oesophagus, a change in the cells of the lower part of the oesophagus, and possible cancer. According to the BBC, this change affects between 1 and 2 adults in 100; most will not go on to develop cancer. NICE adds that the tools could also be used to monitor people who have already been diagnosed.

A question of capacity

NICE believes the tests would ease pressure on endoscopy services, which are in high demand: in some areas, patients with Barrett's oesophagus are not checked as often as current guidance says they should be. Professor Jonathan Benger, NICE's chief executive, describes a "quick and less invasive" way of spotting worrying changes. Professor Peter Johnson, NHS England's national clinical lead for cancer, tells the BBC that thousands of people have already benefited from the test in pilot projects.

Limits that were pointed out

According to the BBC, NICE stresses that no test, endoscopy included, identifies every case: a normal result does not remove the need for long-term follow-up. For now this is a draft: final recommendations are expected in the new year, according to the BBC. The statement says these are the first outputs of a new national programme for access to health technologies, meant to make recommended devices available consistently across the country.

Why it matters

The recommendations aim to make these tests available more widely in the English health system, away from hospitals. The text remains provisional and open to consultation; it concerns the English health system and says nothing about what will be decided elsewhere.

Sources